インドの体外受精機器市場の評価：製品タイプ別、手順タイプ別、エンドユーザー別、地域別、機会および予測、2018～2032年

インドの体外受精機器市場は、2025～2032年度の予測期間中にCAGR 7.70％を記録し、2024年度の11億3,000万米ドルから2032年度には20億5,000万米ドルに成長すると予測されています。

インドの体外受精機器市場は、最近の体外受精技術の進歩や効率的なソリューションに対する需要の高まりにより大きく成長しています。同国の市場拡大を後押しする主な要因のひとつは、座りがちなライフスタイルや環境条件の変化により、国民の多くが生殖機能を低下させていることです。生殖医療にまつわるタブーは徐々に解消されつつあり、人々の意識が全国に広まるにつれて、こうした医療オプションをより自由に利用するようになっています。さらに、ヘルスケア・インフラに対する政府の投資、技術の進歩、最先端のソリューションに対する需要の高まりが、市場の成長軌道を強化しています。特にアジア太平洋におけるヘルスケアの急速な進歩は、有利な見通しをもたらしています。例えば、ケララ州を拠点とする体外受精病院であるサビーン病院は2024年2月、胎児がまだ子宮内にいる間に遺伝性疾患を特定する最新鋭の機械を導入すると発表しました。次世代シークエンサー（NGS）として知られるこの機械は、発育中の胎児の遺伝子疾患を検出するために使用されます。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 インドの体外受精機器市場の見通し、2018年～2032年

• 市場規模の分析と予測
  • 金額別
• 市場シェア分析と予測
  • 製品タイプ別
    • 装置
    • 試薬と培地
    • ソフトウェアとサービス
  • 手順タイプ別
    • 新鮮ドナーによる体外受精
    • 新鮮な非ドナー体外受精
    • 凍結ドナー体外受精
    • 凍結非ドナー体外受精
    • 自然周期体外受精
    • その他
  • エンドユーザー別
    • 不妊治療クリニック
    • 病院
    • 調査機関および学術センター
    • クライオバンク
  • 地域別
    • 北部
    • 南部
    • 東部
    • 西部と中部
  • 市場シェア分析（上位5社およびその他- 金額別、2024年）、企業別
• 市場マップ分析、2024年
  • 製品タイプ別
  • 手順タイプ別
  • エンドユーザー別
  • 地域別

すべてのセグメントは、対象となるすべての地域と国で提供されます。

第5章 需要供給分析

第6章 輸入と輸出の分析

第7章 バリューチェーン分析

第8章 ポーターのファイブフォース分析

第9章 PESTLE分析

第10章 価格分析

第11章 市場力学

• 市場促進要因
• 市場の課題

第12章 市場の動向と発展

第13章 規制枠組みとイノベーション

• 臨床試験
• 規制当局の承認

第14章 特許の情勢

第15章 ケーススタディ

第16章 競合情勢

• 市場リーダー上位5社の競合マトリックス
• 上位5社のSWOT分析
• 市場上位10社の主要企業の情勢
  • CK Birla Healthcare Pvt. Ltd.
  • 会社概要
  • 主要経営陣
  • 製品とサービス
  • 財務状況（報告通り）
  • 主な市場フォーカスと地理的プレゼンス
  • 最近の動向/コラボレーション/ パートナーシップ/合併と買収
  • STECH IVF Solutions Private Limited
  • ShineLife Meditec LLP
  • Shivani Scientific Industries（P）Ltd.
  • Navdurga Scientific Pvt. Ltd.
  • Vardhman Medicare Pvt. Ltd.
  • SAR Healthline Private Limited
  • Amensco Medical Technologies Pvt. Ltd.
  • Esco Lifesciences Group
  • IMV Technologies Group（Cryo Bio System）

上記の企業は市場シェアに基づいて注文を保留しておらず、調査作業中に入手可能な情報に基づいて変更される可能性があります。

第17章 戦略的提言

第18章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India In-Vitro Fertilization Market, By Value, In USD Billion, FY2018-FY2032F
• Figure 2. India In-Vitro Fertilization Market Share (%), By Product Type, FY2018-FY2032F
• Figure 3. India In-Vitro Fertilization Market Share (%), By Procedure Type, FY2018-FY2032F
• Figure 4. India In-Vitro Fertilization Market Share (%), By End-user, FY2018-FY2032F
• Figure 5. India In-Vitro Fertilization Market Share (%), By Region, FY2018-FY2032F
• Figure 6. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 7. By Procedure Type Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 8. By End-user Map-Market Size (USD Billion) & Growth Rate (%), FY2024
• Figure 9. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2024

India in-vitro fertilization instruments market is projected to witness a CAGR of 7.70% during the forecast period FY2025-FY2032F, growing from USD 1.13 billion in FY2024 to USD 2.05 billion in FY2032.

The in-vitro fertilization instruments market in India has grown significantly because of recent advancements in IVF techniques and the growing demand for efficient solutions. One of the primary factors propelling market expansions in the country is most of the population's declining reproductive health due to sedentary lifestyles and shifting environmental conditions. The taboo still associated with it is gradually dissolving and people are more freely availing these medical options as awareness spreads countrywide. Furthermore, government investments in healthcare infrastructure, technological advancements, and the growing demand for cutting-edge solutions reinforce the market's growth trajectory. Rapid advancements in healthcare, particularly in Asia-Pacific, present lucrative prospects. For example, the Sabine Hospital, an IVF hospital based in Kerala, announced in February 2024 that it was all set to install its new and advanced machine to identify genetic diseases while the fetus was still in the womb. This machine, known as the Next Generation Sequencer (NGS), is used to detect genetic diseases in the developing fetus.

Rising Acceptance and Awareness about In-Vitro Fertilization (IVF) Boosts Market Growth

The expansion of India's fertility business has been greatly aided by the increasing awareness and public acceptance of in-vitro fertilization (IVF). Infertility was once a taboo topic, but because of healthcare initiatives, media influence, and education, there is now more openness and acceptance of IVF procedures.

Due to better access to information through digital platforms and healthcare campaigns, couples who have trouble conceiving are now more likely to look for medical options. Furthermore, IVF is now more widely available due to the growth of fertility clinics in Tier 2 and Tier 3 cities, affordable treatment choices, and government initiatives. The industry has grown on the backdrop of shifting attitudes, the acceptance of IVF among LGBTQ+ people and single parents, and corporate insurance coverage for fertility treatments.

For instance, Nova IVF introduced "Fertility Tales," a podcast project in November 2023, to raise awareness about fertility treatment through engaging narratives. The podcast interviews industry stakeholders and shares real patient stories about firsthand experiences with IVF treatment.

Rising Infertility Rate Accelerates India In-Vitro Fertilization (IVF) Instruments Market Growth

The need for in-vitro fertilization (IVF) is being greatly increased by the steep increase in infertility rates in India. The main causes of infertility in both men and women are changing lifestyles, stress, late marriages, obesity, pollution, and rising health disorders such as diabetes and PCOS. Infertility problems affect approximately 10-15% of Indian couples, with a higher prevalence in metropolitan areas, according to the Indian Society of Assisted Reproduction (ISAR).

The spike in infertility cases has spurred the growth of IVF clinics and fertility centres across India. Couples are now more inclined to pursue IVF treatments due to rising awareness, affordability, and technological advancements including AI-driven embryo selection and enhanced cryopreservation techniques. Fertility treatments are also becoming more widely available in India due to initiatives taken by our government and the country's expanding medical tourism.

As infertility cases continue to rise, the Indian IVF market is expected to witness exponential growth in the coming years. For instance, the government of Goa launched the Intrauterine Insemination /In Vitro Fertilization and Assisted Reproductive Technology Centre in August 2023 at the Goa Medical College and Hospital (GMC); providing infertility treatment free of cost.

Rising Infrastructure Fuels the India In-Vitro Fertilization (IVF) Instruments Market Growth

India's in-vitro fertilization (IVF) market has grown tremendously because of the nation's rapidly developing healthcare infrastructure. Fertility treatments are now more widely accessible due to the construction of specialized fertility centers, cutting-edge reproductive laboratories, and enhanced hospital facilities throughout metropolitan and semi-urban areas. Prominent healthcare organizations such as Apollo, Fortis, and Nova IVF Fertility have extended their IVF offerings by incorporating state-of-the-art technology such as genetic testing, sophisticated cryopreservation, and AI-based embryo selection. Infrastructure development is accelerated by government efforts such as Public-Private Partnerships (PPP) and greater foreign investments. Furthermore, the growth of medical tourism has drawn people from all over the world due to India's high-quality fertility therapies and affordability. IVF adoption is also fueled by improved healthcare accessibility and connection in tier-2 and tier-3 cities. With continuous investments in healthcare infrastructure and innovation, India's IVF market is set for exponential growth, catering to rising infertility rates and evolving patient needs.

For instance, in January 2024, CK Birla Healthcare Pvt. Ltd. introduced a new fertility clinic in Meerut, Uttar Pradesh that caters to various fertility issues in people.

Future Market Scenario (FY2025 - FY2032F)

Many factors contribute to the growth of India In-vitro fertilization instruments market. Technological advancements give faster and more accurate results leading us to early diagnosis. Opportunity also lies in the increasing fertility concerns the population faces today. Promising initiatives of our government that provide healthcare infrastructure, funds to carry on research and development on a large scale, and a reliable distribution channel that ensures the solution reaches everyone is testimonial.

For instance, in December 2023, Little Angel IVF launched in vitro fertilization treatments such as personalized fertility consultation, comprehensive diagnostic services, advanced IVF treatments, and intracytoplasmic sperm injection (ICSI) for Non-Resident Indian patients.

Key Players Landscape and Outlook

Key players in India's in-vitro fertilization industry utilize strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, in December 2023, Progenesis IVF Private Limited, a renowned genetic testing brand, expanded its operations to India by launching its first genetic laboratory in New Delhi.

In March 2023, Santaan Fertility Center & Research Institute Private Limited launched a new fertility clinic and research institute in the state of Odisha, India and Indira IVF opened its 116th IVF center in Pune, Maharashtra, an addition to the existing center in Pune.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India In-Vitro Fertilization Instruments Market Outlook, FY2018-2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Equipment
      • 4.2.1.1.1. Incubators
      • 4.2.1.1.2. Cryosystem
      • 4.2.1.1.3. Imaging Systems
      • 4.2.1.1.4. Ovum Aspiration Pumps
      • 4.2.1.1.5. Micromanipulators
      • 4.2.1.1.6. Sperm Separation Systems
      • 4.2.1.1.7. Others
    • 4.2.1.2. Reagents and Media
      • 4.2.1.2.1. Embryo Culture Media
      • 4.2.1.2.2. Cryopreservation Media
      • 4.2.1.2.3. Sperm Processing Media
      • 4.2.1.2.4. Others
    • 4.2.1.3. Software and Services
  • 4.2.2. By Procedure Type
    • 4.2.2.1. Fresh Donor IVF
    • 4.2.2.2. Fresh Non-Donor IVF
    • 4.2.2.3. Frozen Donor IVF
    • 4.2.2.4. Frozen Non-Donor IVF
    • 4.2.2.5. Natural Cycle IVF
    • 4.2.2.6. Others
  • 4.2.3. By End-user
    • 4.2.3.1. Fertility Clinics
    • 4.2.3.2. Hospitals
    • 4.2.3.3. Research Institutes and Academic Centers
    • 4.2.3.4. Cryobanks
  • 4.2.4. By Region
    • 4.2.4.1. North
    • 4.2.4.2. South
    • 4.2.4.3. East
    • 4.2.4.4. West & Central
  • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product Type
  • 4.3.2. By Procedure Type
  • 4.3.3. By End-user
  • 4.3.4. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Import and Export Analysis

7. Value Chain Analysis

8. Porter's Five Forces Analysis

9. PESTLE Analysis

10. Pricing Analysis

11. Market Dynamics

• 11.1. Market Drivers
• 11.2. Market Challenges

12. Market Trends and Developments

13. Regulatory Framework and Innovation

• 13.1. Clinical Trials
• 13.2. Regulatory Approvals

14. Patent Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 10 Market Players
  • 16.3.1. CK Birla Healthcare Pvt. Ltd.
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 16.3.2. STECH IVF Solutions Private Limited
  • 16.3.3. ShineLife Meditec LLP
  • 16.3.4. Shivani Scientific Industries (P) Ltd.
  • 16.3.5. Navdurga Scientific Pvt. Ltd.
  • 16.3.6. Vardhman Medicare Pvt. Ltd.
  • 16.3.7. SAR Healthline Private Limited
  • 16.3.8. Amensco Medical Technologies Pvt. Ltd.
  • 16.3.9. Esco Lifesciences Group
  • 16.3.10. IMV Technologies Group (Cryo Bio System)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer